Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 196

1.

Computational Modelling of Metastasis Development in Renal Cell Carcinoma.

Baratchart E, Benzekry S, Bikfalvi A, Colin T, Cooley LS, Pineau R, Ribot EJ, Saut O, Souleyreau W.

PLoS Comput Biol. 2015 Nov 23;11(11):e1004626. doi: 10.1371/journal.pcbi.1004626. eCollection 2015 Nov.

2.

Glioblastoma invasion and cooption depend on IRE1α endoribonuclease activity.

Jabouille A, Delugin M, Pineau R, Dubrac A, Soulet F, Lhomond S, Pallares-Lupon N, Prats H, Bikfalvi A, Chevet E, Touriol C, Moenner M.

Oncotarget. 2015 Sep 22;6(28):24922-34. doi: 10.18632/oncotarget.4679.

3.

Practical Considerations for Omics Experiments in Biomedical Sciences.

Vaudel M, Barsnes H, Bjerkvig R, Bikfalvi A, Selheim F, Berven FS, Daubon T.

Curr Pharm Biotechnol. 2016;17(1):105-14. Review.

PMID:
26278526
4.

INHIBITION OF ERN1 SIGNALING ENZYME AFFECTS HYPOXIC REGULATION OF THE EXPRESSION OF E2F8, EPAS1, HOXC6, ATF3, TBX3 AND FOXF1 GENES IN U87 GLIOMA CELLS.

Minchenko OH, Tsymbal DO, Minchenko DO, Kovalevska OV, Karbovskyi LL, Bikfalvi A.

Ukr Biochem J. 2015 Mar-Apr;87(2):76-87.

PMID:
26255341
5.
6.

Inference of Low and High-Grade Glioma Gene Regulatory Networks Delineates the Role of Rnd3 in Establishing Multiple Hallmarks of Cancer.

Clarke K, Daubon T, Turan N, Soulet F, Mohd Zahari M, Ryan KR, Durant S, He S, Herbert J, Ankers J, Heath JK, Bjerkvig R, Bicknell R, Hotchin NA, Bikfalvi A, Falciani F.

PLoS Genet. 2015 Jul 1;11(7):e1005325. doi: 10.1371/journal.pgen.1005325. eCollection 2015 Jul.

7.

Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells.

Minchenko OH, Tsuchihara K, Minchenko DO, Bikfalvi A, Esumi H.

World J Gastroenterol. 2014 Oct 14;20(38):13705-17. doi: 10.3748/wjg.v20.i38.13705. Review.

8.

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography.

Platonova N, Miquel G, Chiu LY, Taouji S, Moroni E, Colombo G, Chevet E, Sue SC, Bikfalvi A.

PLoS One. 2014 Oct 9;9(10):e110055. doi: 10.1371/journal.pone.0110055. eCollection 2014.

9.

Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases.

Sfaxi F, Scamuffa N, Lalou C, Ma J, Metrakos P, Siegfried G, Ragg H, Bikfalvi A, Calvo F, Khatib AM.

Oncotarget. 2014 Jun 30;5(12):4195-210.

10.

VEGF modulates synaptic activity in the developing spinal cord.

Guérit S, Allain AE, Léon C, Cazenave W, Ferrara N, Branchereau P, Bikfalvi A.

Dev Neurobiol. 2014 Nov;74(11):1110-22. doi: 10.1002/dneu.22187. Epub 2014 May 24.

11.

High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor.

Auf G, Jabouille A, Delugin M, Guérit S, Pineau R, North S, Platonova N, Maitre M, Favereaux A, Vajkoczy P, Seno M, Bikfalvi A, Minchenko D, Minchenko O, Moenner M.

BMC Cancer. 2013 Dec 13;13:597. doi: 10.1186/1471-2407-13-597.

12.

Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5.

Exertier P, Javerzat S, Wang B, Franco M, Herbert J, Platonova N, Winandy M, Pujol N, Nivelles O, Ormenese S, Godard V, Becker J, Bicknell R, Pineau R, Wilting J, Bikfalvi A, Hagedorn M.

Oncotarget. 2013 Dec;4(12):2302-16.

13.

CXCR3, a double-edged sword in tumor progression and angiogenesis.

Billottet C, Quemener C, Bikfalvi A.

Biochim Biophys Acta. 2013 Dec;1836(2):287-95. doi: 10.1016/j.bbcan.2013.08.002. Epub 2013 Aug 27. Review.

PMID:
23994549
14.

Regulation of the Src kinase-associated phosphoprotein 55 homologue by the protein tyrosine phosphatase PTP-PEST in the control of cell motility.

Ayoub E, Hall A, Scott AM, Chagnon MJ, Miquel G, Hallé M, Noda M, Bikfalvi A, Tremblay ML.

J Biol Chem. 2013 Sep 6;288(36):25739-48. doi: 10.1074/jbc.M113.501007. Epub 2013 Jul 29.

15.

CXCL4L1-fibstatin cooperation inhibits tumor angiogenesis, lymphangiogenesis and metastasis.

Prats AC, Van den Berghe L, Rayssac A, Ainaoui N, Morfoisse F, Pujol F, Legonidec S, Bikfalvi A, Prats H, Pyronnet S, Garmy-Susini B.

Microvasc Res. 2013 Sep;89:25-33. doi: 10.1016/j.mvr.2013.05.005. Epub 2013 Jun 4.

PMID:
23747987
16.

Altered angiogenesis in low birth weight individuals: a role for anti-angiogenic circulating factors.

Ligi I, Simoncini S, Tellier E, Grandvuillemin I, Marcelli M, Bikfalvi A, Buffat C, Dignat-George F, Anfosso F, Simeoni U.

J Matern Fetal Neonatal Med. 2014 Feb;27(3):233-8. doi: 10.3109/14767058.2013.807237. Epub 2013 Jun 20.

PMID:
23701307
17.

Mapping the extracellular and membrane proteome associated with the vasculature and the stroma in the embryo.

Soulet F, Kilarski WW, Roux-Dalvai F, Herbert JM, Sacewicz I, Mouton-Barbosa E, Bicknell R, Lalor P, Monsarrat B, Bikfalvi A.

Mol Cell Proteomics. 2013 Aug;12(8):2293-312. doi: 10.1074/mcp.M112.024075. Epub 2013 May 14.

18.

Alternative C-terminal helix orientation alters chemokine function: structure of the anti-angiogenic chemokine, CXCL4L1.

Kuo JH, Chen YP, Liu JS, Dubrac A, Quemener C, Prats H, Bikfalvi A, Wu WG, Sue SC.

J Biol Chem. 2013 May 10;288(19):13522-33. doi: 10.1074/jbc.M113.455329. Epub 2013 Mar 27.

19.

Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1.

Platonova N, Miquel G, Regenfuss B, Taouji S, Cursiefen C, Chevet E, Bikfalvi A.

Blood. 2013 Feb 14;121(7):1229-37. doi: 10.1182/blood-2012-08-450502. Epub 2012 Dec 20.

20.

The experimental renal cell carcinoma model in the chick embryo.

Fergelot P, Bernhard JC, Soulet F, Kilarski WW, Léon C, Courtois N, Deminière C, Herbert JM, Antczak P, Falciani F, Rioux-Leclercq N, Patard JJ, Ferrière JM, Ravaud A, Hagedorn M, Bikfalvi A.

Angiogenesis. 2013 Jan;16(1):181-94. doi: 10.1007/s10456-012-9311-z. Epub 2012 Oct 18.

PMID:
23076651
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk